Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Accepted on 21 Apr 2025

Construction of a Stromal Cell-Related Prognostic Signature Based on a 101-Combination Machine Learning Framework for Predicting Prognosis and Immunotherapy Response in Triple-Negative Breast Cancer

in Cancer Immunity and Immunotherapy

Fanrong Li
Congnan Jin
Yacheng Pan
Zheng Zhang
Wang Liying
Jieqiong Deng
Yifeng Zhou
Binbin Guo
Shenghua Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1544348

Review

Accepted on 21 Apr 2025

Lactate-Mediated Metabolic Reprogramming of Tumor-Associated Macrophages: Implications for Tumor Progression and Therapeutic Potential

in Cancer Immunity and Immunotherapy

Xiaohan Jin
Ni Zhang
Tinghao Yan
Jingyang Wei
Lingli Hao
Changgang Sun
Haibo Zhao
Shulong Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1573039

Clinical Trial

Accepted on 21 Apr 2025

Pathological complete response and prognostic predictive factors of neoadjuvant chemoimmunotherapy in early stage triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Xuwei Chen
Hengming Ye
DaMing Xu
Siqi Chen
Wei Wu
Xiaoyu Qian
Xinyu Zhang
Xuxiazi Zou
Junquan Chen
Xi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1570394

Original Research

Accepted on 21 Apr 2025

Deciphering the Multifaceted Role of EXO1 in Female-Related Cancers: Implications for Prognosis and Therapeutic Responsiveness

in Cancer Immunity and Immunotherapy

Cong Yu
Guoying Wu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1591505

Systematic Review

Accepted on 21 Apr 2025

Elevated platelet-to-lymphocyte ratio predicts poor clinical outcomes in non-muscle invasive bladder cancer: a systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Wenfeng Hu
Jinze Liang
Huaichun Hu
Jie Fan
Jin Luo
Xinwen Wang
Peng Zhou
Xiaoyi Zhang
Jie Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578069

Original Research

Accepted on 21 Apr 2025

Bibliometric analysis and visualization of Connexin 43 in the field of solid tumor research (2000-2024)

in Cancer Immunity and Immunotherapy

Caiqi Huang
Yanhui Feng
Xiaoman Liu
Zhesi Xiao
Zhengjia Lu
Lu Wang
Jia Ming

Frontiers in Immunology

doi 10.3389/fimmu.2025.1588828

Original Research

Accepted on 21 Apr 2025

Tandem CAR T-cells targeting CD19 and NKG2DL can overcome CD19 antigen escape in B-ALL

in Cancer Immunity and Immunotherapy

Jennifer Bolsée
Benjamin Violle
Céline Jacques-Hespel
Thuy Nguyen
Caroline Lonez
Eytan Breman

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557405

Original Research

Accepted on 21 Apr 2025

Toll-like Receptor 3 Activation Enhances Antitumor Immune Response in Lung Adenocarcinoma through NF-κB Signaling Pathway

in Cancer Immunity and Immunotherapy

Ang Li
Xiyao Liu
Hongjiao Wu
Xiaoguang Liu
Zhi Zhang
Xuemei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1585747

Mini Review

Accepted on 21 Apr 2025

Mechanisms of Autoimmune-Mediated Paraneoplastic Syndromes: Immune Tolerance and Disease Pathogenesis

in Cancer Immunity and Immunotherapy

Cesar Perez Bucio
Anish Behere
Nils Landegren

Frontiers in Immunology

doi 10.3389/fimmu.2025.1608934

Original Research

Accepted on 21 Apr 2025

CBD promotes antitumor activity by modulating tumor immune microenvironment in HPV associated Head and Neck Squamous Cell Carcinoma

in Cancer Immunity and Immunotherapy

Prakriti Sen
Sayed Sadat
Koji Ebisumoto
Riyam Al Msari
Sayuri Miyauchi
Souvick Roy
Pardis Mohammadzadeh
Kristin Lips
Takuya Nakagawa
Robert Saddawi Konefka

Frontiers in Immunology

doi 10.3389/fimmu.2025.1528520

Mini Review

Accepted on 21 Apr 2025

Ultrasound-assisted Immunotherapy for Malignant Tumor

in Cancer Immunity and Immunotherapy

XIAOWEN CAI
Yujie Liu
Guosheng Luo
Zhanwang Yu
Cheng Jiang
Chuanshan Xu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1547594

Mini Review

Accepted on 21 Apr 2025

The distinct role of IL-34 and IL-35 in gastric cancer

in Cancer Immunity and Immunotherapy

Zhiyun He
Jie Dang
Xiang Cui
Bo Li
Shisan Bao
Jingchun Fan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1559508

Systematic Review

Accepted on 21 Apr 2025

A Comprehensive Bibliometric Analysis of Ferroptosis in Tumor Resistance: Development and Emerging Trends

in Cancer Immunity and Immunotherapy

Liangyun Xie
Yafei Zhang
Xiedong Niu
Kang Yuan
Wenyao Li
Jun Yao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1580222

Original Research

Accepted on 21 Apr 2025

Fusobacterium nucleatum downregulated MLH1 expression in colorectal cancer by activating autophagy-lysosome pathway

in Cancer Immunity and Immunotherapy

Tingting Ding
Minkang Wu
Li Zhao
Hu Liu
Xuanke Cao
Jing Guo
Xingchen Zhu
Lamei Zhao
Heping Zhang
Yaohui Gao

Frontiers in Immunology

doi 10.3389/fimmu.2025.1586146

Systematic Review

Accepted on 21 Apr 2025

Efficacy of Neoadjuvant, Adjuvant, and Perioperative Immunotherapy in Non-Small Cell Lung Cancer Across Different PD-L1 Expression Levels: A Systematic Review and Meta-Analysis

in Cancer Immunity and Immunotherapy

Zhenlong Zhang
Yuchen Lin
Shuchen Chen

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569864

Original Research

Accepted on 21 Apr 2025

Development of a Lung Immune Prognostic Index-Based Nomogram Model for Predicting Overall Survival and Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Treated with Sintilimab

in Cancer Immunity and Immunotherapy

Jian Xu
tingting peng
fan kaikai
dou yuxiao
Lingti Kong
Ran Sang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1569689